Determination of Drug Toxicity Using 3D Spheroids Constructed From an Immortal Human Hepatocyte Cell Line
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Numerous publications have documented that the immortal cells grown in three-dimensional (3D) cultures possess physiological behavior, which is more reminiscent of their parental organ than when the same cells are cultivated using classical two-dimensional (2D) culture techniques. The goal of this study was to investigate whether this observation could be extended to the determination of LD(50) values and whether 3D data could be correlated to in vivo observations. We developed a noninvasive means to estimate the amount of protein present in a 3D spheroid from it is planar area (± 21%) so that a precise dose can be provided in a manner similar to in vivo studies. This avoided correction of the actual dose given based on a protein determination after treatment (when some cells may have lysed). Conversion of published in vitro LC(50) data (mM) for six common drugs (acetaminophen, amiodarone, diclofenac, metformin, phenformin, and valproic acid) to LD(50) data (mg compound/mg cellular protein) showed that the variation in LD(50) values was generally less than that suggested by the original LC(50) data. Toxicological analysis of these six compounds in 3D spheroid culture (either published or presented here) demonstrated similar LD(50) values. Although in vitro 2D HepG2 data showed a poor correlation, the primary hepatocyte and 3D spheroid data resulted in a much higher degree of correlation with in vivo lethal blood plasma levels. These results corroborate that 3D hepatocyte cultures are significantly different from 2D cultures and are more representative of the liver in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“APAP is a wellcharacterized hepatotoxic drug and its in vivo model data is available in literature [73].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“, 2003a); 34, (Zhou et al., 2001); and 35, data presented in this report.”
BackgroundThe third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
Capturing complex 3D tissue physiology in vitro
Griffith, L. G., & Swartz, M. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1858 · Cited by 2,290 · cited 1×
“Three-dimensional (3D) structure has therefore been proposed as the missing link, which will provide in vitro models that sufficiently mimic in vivo conditions (Griffith and Swartz, 2006; Nelson et al., 2010; Pampaloni et al., 2007).”
BackgroundForetz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181 · cited 1×
“, 2008); 5, (Flynn and Ferguson, 2008); 6, (Foretz et al., 2010); 7, (Fulgencio et al.”
Loessner, D., Stok, K. S., Lutolf, M. P., Hutmacher, D. W., Clements, J. A., & Rizzi, S. C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.064 · Cited by 602 · cited 2×
“The reason for this has been suggested to be related to the fact that 3D cell culture allows the cells to develop a more elaborate extracellular matrix and better intercellular communication (Daus et al., 2011; Lin et al., 2006; Loessner et al., 2010), and this leads to a recovery or maintenance of in vivo function (S…”
BackgroundTherapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.
Schulz, M., & Schmoldt, A. (2003) · PubMed · Cited by 439
Riss, T. L., & Moravec, R. A. (2004) · ASSAY and Drug Development Technologies · doi:10.1089/154065804322966315 · Cited by 370 · cited 2×
“, 2010, 2011) and for tamoxifen treatment of HepG2 cells (Riss and Moravec, 2004), and no clear correlation emerged between assay method and LC50 obtained when analyzing the data (see below).”
MethodContribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
MANYIKE, P., KHARASCH, E., KALHORN, T., & SLATTERY, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.104736 · Cited by 355 · cited 1×
“APAP 1A2, 2E1, and 3A4 (Hazai et al., 2002; Manyike et al., 2000) 3 CNS”
Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and β1-integrin
Lin, R.-Z., Chou, L.-F., Chien, C.-C. M., & Chang, H.-Y. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0148-2 · Cited by 305 · cited 1×
“…be related to the fact that 3D cell culture allows the cells to develop a more elaborate extracellular matrix and better intercellular communication (Daus et al., 2011; Lin et al., 2006; Loessner et al., 2010), and this leads to a recovery or maintenance of in vivo function (Selden et al., 2000).”
BackgroundHepaRG Cells: A Human Model to Study Mechanisms of Acetaminophen Hepatotoxicity Δσ
McGill, M. R., Yan, H.-M., Ramachandran, A., Murray, G. J., Rollins, D. E., & Jaeschke, H. (2011) · Hepatology · doi:10.1002/hep.24132 · Cited by 294
Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing
Tostões, R. M., Leite, S. B., Serra, M., Jensen, J., Björquist, P., Carrondo, M. J. T., Brito, C., & Alves, P. M. (2012) · Hepatology · doi:10.1002/hep.24760 · Cited by 246 · cited 1×
“Many of the studies have used primary cells and these have shown that 3D culture prolongs crucial liver-like functionality in primary rat (Brophy et al., 2009; Schutte et al., 2011), porcine (Nelson et al., 2010), and human hepatocytes (Tostoes et al., 2012).”
BackgroundDiclofenac Toxicity to Hepatocytes: A Role for Drug Metabolism in Cell Toxicity
Bort, R., Ponsoda, X., Jover, R., Gómez-Lechón, M. J., & Castell, J. V. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37925-x · Cited by 236
Dykens, J. A., Jamieson, J., Marroquin, L., Nadanaciva, S., Billis, P. A., & Will, Y. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.08.013 · Cited by 220 · cited 2×
“, 2009); 4, (Dykens et al., 2008); 5, (Flynn and Ferguson, 2008); 6, (Foretz et al.”
BackgroundMechanisms of benzarone and benzbromarone‐induced hepatic toxicity†
Kaufmann, P., Török, M., Hänni, A., Roberts, P., Gasser, R., & Krähenbühl, S. (2005) · Hepatology · doi:10.1002/hep.20634 · Cited by 184
Reduction of Toxic Metabolite Formation of Acetaminophen
Hazai, E., Vereczkey, L., & Monostory, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6541 · Cited by 169 · cited 1×
“APAP 1A2, 2E1, and 3A4 (Hazai et al., 2002; Manyike et al., 2000) 3 CNS”
Brophy, C. M., Luebke-Wheeler, J. L., Amiot, B. P., Khan, H., Remmel, R. P., Rinaldo, P., & Nyberg, S. L. (2009) · Hepatology · doi:10.1002/hep.22674 · Cited by 149 · cited 2×
“primary cells and these have shown that 3D culture prolongs crucial liver-like functionality in primary rat (Brophy et al., 2009; Schutte et al., 2011), porcine (Nelson et al.”
BackgroundElkayam, T., Amitay-Shaprut, S., Dvir-Ginzberg, M., Harel, T., & Cohen, S. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.1357 · Cited by 130 · cited 1×
“…have used primary hepatocytes, there are several reports in the literature that illustrate that immortal hepatocytes also can recover crucial liver-like functionality and that this might increase their value for toxicological studies (Elkayam et al., 2006; Selden et al., 2000; Xu et al., 2003a,b).”
BackgroundThe role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells
Zahno, A., Brecht, K., Morand, R., Maseneni, S., Török, M., Lindinger, P. W., & Krähenbühl, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.002 · Cited by 117 · cited 1×
“Amiodarone 3A4 (Zahno et al., 2011) 75 Cardiac cells Diclofenac 2C9 (Mancy et al.”
BackgroundLin, J., Schyschka, L., Mühl‐Benninghaus, R., Neumann, J., Hao, L., Nüssler, N. C., Dooley, S., Liu, L., Stöckle, U., Nussler, A. K., et al. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0733-y · Cited by 113 · cited 10×
“8mM for cell lines (Huh-7 (Lin et al., 2012), HCC-T (Lin et al.”
BackgroundMethodInfluentialWANG, K., SHINDOH, H., INOUE, T., & HORII, I. (2002) · The Journal of Toxicological Sciences · doi:10.2131/jts.27.229 · Cited by 106 · cited 3×
“For example, the highest LC50 concentration described in the literature for APAP is 29.75mM using HepG2 cells (Wang et al., 2002) and the lowest is 0.137mM using Huh-7 cells (Lin et al., 2012), giving a maximum ratio of 218.”
BackgroundMethodInfluentialFulgencio, J.-P., Kohl, C., Girard, J. R., & Pégorier, J. P. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00679-7 · Cited by 99 · cited 1×
“, 2010); 7, (Fulgencio et al., 2001); 8, (Golli-Bennour et al.”
Interspecies differences in acetaminophen sensitivity of human, rat, and mouse primary hepatocytes
Jemnitz, K., Veres, Z., Monostory, K., Kob́ori, L., & Vereczkey, L. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.02.001 · Cited by 99 · cited 7×
“In making the comparison to the published in vivo plasma concentrations, only data based on human hepatocytes were used in the APAP correlation because it has been shown that humans and rodents respond differently to APAP (Jemnitz et al., 2008).”
BackgroundMethodInfluentialRettie, A. E., Sheffels, P. R., Korzekwa, K. R., Gonzalez, F. J., Philpot, R. M., & Baillie, T. A. (1995) · Biochemistry · doi:10.1021/bi00024a013 · Cited by 94
Cytometric analysis for drug-induced steatosis in HepG2 cells
Donato, M. T., Martínez‐Romero, A., Jiménez, N., Negro, A., Herrera, G., Castell, J. V., O’Connor, J., & Gómez‐Lechón, M. J. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.07.019 · Cited by 85 · cited 1×
“, 1998); 3, (Donato et al., 2009); 4, (Dykens et al.”
The Toxicity of Metabolites of Sodium Valproate in Cultured Hepatocytes
Kingsley, E., Gray, P. D., Tolman, K. G., & Tweedale, R. (1983) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1983.tb02722.x · Cited by 83 · cited 1×
“, 2010); 14, (Kingsley et al., 1983); 15, (Lauer et al.”
Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes
Lauer, B., Tuschl, G., Kling, M., & Mueller, S. O. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.031 · Cited by 83 · cited 1×
“, 1983); 15, (Lauer et al., 2009); 16, (Lewerenz et al.”
Xu, J., Ma, M., & Purcell, W. M. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00089-9 · Cited by 81 · cited 4×
“4C) (Xu et al., 2003a,b).”
BackgroundMethodInfluentialDiclofenac induces apoptosis in hepatocytes
Gómez-Lechón, M. J., Ponsoda, X., O’Connor, E., Donato, M. T., Jover, R., & Castell, J. V. (2003) · Toxicology in Vitro · doi:10.1016/s0887-2333(03)00105-x · Cited by 77 · cited 1×
“, 2012); 9, (Gomez-Lechon et al., 2003); 10, (Jemnitz et al.”
Mancy, A., Antignac, M., Minoletti, C., Dijols, S., Mouries, V., Ha Duong, N.-T., Battioni, P., Dansette, P. M., & Mansuy, D. (1999) · Biochemistry · doi:10.1021/bi991195u · Cited by 77
Boobis, A. R., Murray, S., Kahn, G. C., Robertz-Vaupel, G.-M., & Davies, D. S. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14267-3 · Cited by 76 · cited 1×
“, 2010) 3 Liver Phenformin 1A1, 2D6 (Boobis et al., 1983; Granvil et al., 2002) 7 Liver”
Sakai, Y., Yamagami, S., & Nakazawa, K. (2010) · Cells Tissues Organs · doi:10.1159/000272316 · Cited by 72 · cited 2×
“…al., 2011) enhances drug efflux activities (Oshikata et al., 2011) and preserves (compared with adult liver) gene expression of several key hepatic markers (including adhesion molecules, transcription factors, metabolic enzymes including cytochrome P450, and transporters) (Sakai et al., 2010).”
BackgroundSchutte, M., Fox, B., Baradez, M.-O., Devonshire, A., Minguez, J., Bokhari, M., Przyborski, S., & Marshall, D. (2011) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2011.0371 · Cited by 72 · cited 2×
“primary cells and these have shown that 3D culture prolongs crucial liver-like functionality in primary rat (Brophy et al., 2009; Schutte et al., 2011), porcine (Nelson et al.”
BackgroundMcCarthy, T. C., Pollak, P. T., Hanniman, E. A., & Sinal, C. J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.072785 · Cited by 63 · cited 1×
“, 2012); 18, (McCarthy et al., 2004); 19, (McGill et al.”
CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity
Neuman, M. G., Shear, N. H., Jacobson-Brown, P., Katz, G. G., Neilson, H. K., Malkiewicz, I. M., Cameron, R., & Abbott, F. S. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00217-x · Cited by 63
Oshikata, A., Matsushita, T., & Ueoka, R. (2011) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2011.01.006 · Cited by 62 · cited 2×
“, 2011) enhances drug efflux activities (Oshikata et al., 2011) and preserves (compared with adult liver) gene”
BackgroundLewerenz, V., Hanelt, S., Nastevska, C., El-Bahay, C., Röhrdanz, E., & Kahl, R. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00256-7 · Cited by 59 · cited 1×
“…(Jemnitz et al., 2008; Lin et al., 2012; Riches et al., 2009; Ullrich et al., 2009); from 7.6 to 25mM for rat hepatocytes (Jemnitz et al., 2008; Lewerenz et al., 2003; Wang et al., 2002); from 3.8 to 20mM for mouse hepatocytes (Jemnitz et al., 2008; Moon et al., 2010; Toyoda et al., 2012); and…”
BackgroundInfluentialKiang, T. K. L., Teng, X. W., Surendradoss, J., Karagiozov, S. K., Abbott, F. S., & Chang, T. K. H. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.03.004 · Cited by 55 · cited 1×
“…used for determining the LC50 because assay differences were shown to be minimal for VPA treatment of rat hepatocytes grown in sandwich cultures (Kiang et al., 2010, 2011) and for tamoxifen treatment of HepG2 cells (Riss and Moravec, 2004), and no clear correlation emerged between assay method…”
MethodKiang, T. K. L., Teng, X. W., Karagiozov, S. K., Surendradoss, J., Chang, T. K. H., & Abbott, F. S. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq294 · Cited by 55 · cited 1×
“…used for determining the LC50 because assay differences were shown to be minimal for VPA treatment of rat hepatocytes grown in sandwich cultures (Kiang et al., 2010, 2011) and for tamoxifen treatment of HepG2 cells (Riss and Moravec, 2004), and no clear correlation emerged between assay method…”
MethodSelden, C., Khalil, M., & Hodgson, H. (2000) · The International Journal of Artificial Organs · doi:10.1177/039139880002301107 · Cited by 49 · cited 3×
“…have used primary hepatocytes, there are several reports in the literature that illustrate that immortal hepatocytes also can recover crucial liver-like functionality and that this might increase their value for toxicological studies (Elkayam et al., 2006; Selden et al., 2000; Xu et al., 2003a,b).”
BackgroundChoi, Y., Lee, U., Lee, B., & Lee, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00913.x · Cited by 47 · cited 1×
“5 Inflammatory cells Metformin 3A4 (Choi et al., 2010) 3 Liver Phenformin 1A1, 2D6 (Boobis et al.”
BackgroundCytotoxicity effects of amiodarone on cultured cells
Golli‐Bennour, E. E., Bouslimi, A., Zouaoui, O., Nouira, S., Achour, A., & Bacha, H. (2010) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2010.10.008 · Cited by 45 · cited 1×
“, 2001); 8, (Golli-Bennour et al., 2012); 9, (Gomez-Lechon et al.”
Ponsoda, X., Bort, R., Jover, R., Gómez‐Lechón, M. J., & Castell, J. V. (1995) · Toxicology in Vitro · doi:10.1016/0887-2333(95)00035-7 · Cited by 44 · cited 2×
“…addition, it is known that different cell lines exhibit different abilities to metabolize drugs (e.g., diclofenac metabolism in rat primary hepatocytes, rat FaO cells and human HepG2 cells [Ponsoda et al., 1995], and APAP metabolism in human hepatocytes, Huh-7. and HCC-T cells [Lin et al., 2012]).”
BackgroundPhospholipidosis Assay in HepG2 Cells and Rat or Rhesus Hepatocytes Using Phospholipid Probe NBD-PE
Bhandari, N., Figueroa, D. J., Lawrence, J. W., & Gerhold, D. L. (2008) · Assay and Drug Development Technologies · doi:10.1089/adt.2007.119 · Cited by 42 · cited 2×
“Most LD50 studies of amiodarone have been carried out using either rat hepatocytes or HepG2 cells, although one study used rhesus monkey hepatocytes (open square in figure 4B) (Bhandari et al., 2008).”
Background4-Hydroxylation of Debrisoquine by Human CYP1A1 and Its Inhibition by Quinidine and Quinine
Granvil, C. P., Krausz, K. W., Gelboin, H. V., Idle, J. R., & Gonzalez, F. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1025 · Cited by 42 · cited 1×
“, 2010) 3 Liver Phenformin 1A1, 2D6 (Boobis et al., 1983; Granvil et al., 2002) 7 Liver”
Sodium valproate induces apoptosis in the rat hepatoma cell line, FaO
Phillips, A., Bullock, T., & Plant, N. J. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00331-7 · Cited by 41
Use of population modeling to define rational monitoring of amiodarone hepatic effects*1
POLLAK, P. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.12.008 · Cited by 38 · cited 1×
“Therefore, in order to benchmark the data and evaluate its relevance to assessing human toxicity in vivo, the data was compared with published plasma concentrations (lg/ml) which either produced a comatose state or were lethal in vivo in man (Pollak and Shafer, 2004; Schulz and Schmoldt, 2003) (Fig.”
ResultLong term cultures of primary human hepatocytes as an alternative to drug testing in animals
Ullrich, A. (2009) · ALTEX · doi:10.14573/altex.2009.4.295 · Cited by 37 · cited 3×
“Published LC50 values vary considerably from 0.21 to 28.2mM for human hepatocytes (Jemnitz et al., 2008; Lin et al., 2012; Riches et al., 2009; Ullrich et al., 2009); from 7.6 to 25mM for rat hepatocytes (Jemnitz et al., 2008; Lewerenz et al., 2003; Wang et al., 2002); from 3.8 to 20mM for mouse…”
BackgroundInfluentialFlynn, T. J., & Ferguson, M. S. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.04.016 · Cited by 37 · cited 9×
“…et al., 2002); from 3.8 to 20mM for mouse hepatocytes (Jemnitz et al., 2008; Moon et al., 2010; Toyoda et al., 2012); and from 0.14 to 29.8mM for cell lines (Huh-7 (Lin et al., 2012), HCC-T (Lin et al., 2012), C3A (Flynn and Ferguson, 2008), and HepG2 (Miyamoto et al., 2009b; Wang et al., 2002).”
BackgroundInfluentialNelson, L. J., Walker, S. W., Hayes, P. C., & Plevris, J. N. (2010) · Cells Tissues Organs · doi:10.1159/000308893 · Cited by 37 · cited 3×
“, 2011), porcine (Nelson et al., 2010), and human hepatocytes (Tostoes et al.”
BackgroundXu, J., Ma, M., & Purcell, W. M. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00090-5 · Cited by 34 · cited 4×
“4C) (Xu et al., 2003a,b).”
BackgroundMethodInfluentialToyoda, Y., Tamai, M., Kashikura, K., Kobayashi, S., Fujiyama, Y., Soga, T., & Tagawa, Y. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.041137 · Cited by 34 · cited 2×
“…(Jemnitz et al., 2008; Lewerenz et al., 2003; Wang et al., 2002); from 3.8 to 20mM for mouse hepatocytes (Jemnitz et al., 2008; Moon et al., 2010; Toyoda et al., 2012); and from 0.14 to 29.8mM for cell lines (Huh-7 (Lin et al., 2012), HCC-T (Lin et al., 2012), C3A (Flynn and Ferguson, 2008), and…”
BackgroundInfluentialInteraction with the hERG channel and cytotoxicity of amiodarone and amiodarone analogues
Waldhauser, K., Brecht, K., Hebeisen, S., Ha, H. R., Konrad, D., Bur, D., & Krähenbühl, S. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.287 · Cited by 32 · cited 1×
“, 2009); 31, (Waldhauser et al., 2008); 32, (Wang et al.”
Okamoto, T., Kanemoto, N., Ban, T., Sudo, T., Nagano, K., & Niki, I. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.09.015 · Cited by 31 · cited 2×
“Because of the effects of metformin on glucose metabolism, only studies, which investigated metformin’s toxicity using alternative carbon sources (e.g., galactose [Dykens et al., 2008] or pyruvate [Okamoto et al., 2009]), were used for data analysis.”
BackgroundJi, Q., Shi, X., Lin, R., Mao, Y., Zhai, X., Lin, Q., & Zhang, J. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.03.014 · Cited by 31
Riches, Z., Bloomer, J. C., Patel, A. H., Nolan, A., & Coughtrie, M. W. H. (2009) · Xenobiotica · doi:10.1080/00498250902763440 · Cited by 31 · cited 2×
“Published LC50 values vary considerably from 0.21 to 28.2mM for human hepatocytes (Jemnitz et al., 2008; Lin et al., 2012; Riches et al., 2009; Ullrich et al., 2009); from 7.6 to 25mM for rat hepatocytes (Jemnitz et al., 2008; Lewerenz et al., 2003; Wang et al., 2002); from 3.8 to 20mM for mouse…”
BackgroundInfluentialElectromagnetic exposure of scaffold-free three-dimensional cell culture systems
Daus, A. W., Goldhammer, M., Layer, P. G., & Thielemann, C. (2011) · Bioelectromagnetics · doi:10.1002/bem.20649 · Cited by 25 · cited 2×
“The reason for this has been suggested to be related to the fact that 3D cell culture allows the cells to develop a more elaborate extracellular matrix and better intercellular communication (Daus et al., 2011; Lin et al., 2006; Loessner et al., 2010), and this leads to a recovery or maintenance of in vivo function (S…”
BackgroundMoon, M. S., Richie, J. P., & Isom, H. C. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq230 · Cited by 25 · cited 2×
“…for rat hepatocytes (Jemnitz et al., 2008; Lewerenz et al., 2003; Wang et al., 2002); from 3.8 to 20mM for mouse hepatocytes (Jemnitz et al., 2008; Moon et al., 2010; Toyoda et al., 2012); and from 0.14 to 29.8mM for cell lines (Huh-7 (Lin et al., 2012), HCC-T (Lin et al., 2012), C3A (Flynn and…”
BackgroundInfluentialMiyamoto, S., Matsumoto, A., Mori, I., & Horinouchi, A. (2009) · Toxicology Mechanisms and Methods · doi:10.1080/15376510903322834 · Cited by 23 · cited 1×
“…et al., 2002); from 3.8 to 20mM for mouse hepatocytes (Jemnitz et al., 2008; Moon et al., 2010; Toyoda et al., 2012); and from 0.14 to 29.8mM for cell lines (Huh-7 (Lin et al., 2012), HCC-T (Lin et al., 2012), C3A (Flynn and Ferguson, 2008), and HepG2 (Miyamoto et al., 2009b; Wang et al., 2002).”
BackgroundInfluentialUbl, J. J., Chen, S., & Stucki, J. W. (1994) · Biochemical Journal · doi:10.1042/bj3040561 · Cited by 18
Rauchenzauner, M., Laimer, M. W., Luef, G. J., Kaser, S., Engl, J., Tatarczyk, T., Ciardi, C., Tschoner, A., Lechleitner, M., Patsch, J. R., et al. (2008) · Seizure · doi:10.1016/j.seizure.2008.03.002 · Cited by 15 · cited 1×
“, 1995); 26, (Rauchenzauner et al., 2008); 27, (Riches et al.”
78 Mechanisms of benzarone and benzbromarone induced hepatic toxicity
Kaufmann, P., Török, M., Hänni, A., Gasser, R. B., & Krähenbühl, S. (2004) · Journal of Hepatology · doi:10.1016/s0168-8278(04)90078-5 · Cited by 9
Adachi, T., Goto, M., Cho, C., & Akaike, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.004 · Cited by 5 · cited 2×
“Spheroid formation maintains cytochrome P450 expression (Adachi et al., 2011) enhances drug efflux activities (Oshikata et al., 2011) and preserves (compared with adult liver) gene expression of several key hepatic markers (including adhesion molecules, transcription factors, metabolic enzymes…”
BackgroundA protein assay for heme oxygenase-1 (HO-1) induced by chemicals in HepG2 cells
Miyamoto, Y., Ohshida, K., & Sasago, K. (2009) · The Journal of Toxicological Sciences · doi:10.2131/jts.34.709 · Cited by 5
Research works printed but not linked: 1
- Wrzesinski, 2009, Molecular Markers Associated With Hepatotoxicity: Development of In Vitro Test System Based on Human Cells
Cited by
A liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
Challenges of applying multicellular tumor spheroids in preclinical phase
Han, S. J., Kwon, S., & Kim, K. S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01853-8 · Cited by 428
Ramaiahgari, S. C., den Braver, M. W., Herpers, B., Terpstra, V., Commandeur, J. N. M., van de Water, B., & Price, L. S. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1215-9 · Cited by 364
Multi-cell type human liver microtissues for hepatotoxicity testing
Messner, S., Agarkova, I., Moritz, W., & Kelm, J. M. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-0968-2 · Cited by 319
Barbosa, M. A. G., Xavier, C. P. R., Pereira, R. F., Petrikaitė, V., & Vasconcelos, M. H. (2021) · Cancers · doi:10.3390/cancers14010190 · Cited by 285
Metadata
- Authors
- Fey, S. J., & Wrzesinski, K.
- Affiliations
- University of Southern Denmark (DK)
- Corresponding author
- Fey, Stephen J.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-27
- Volume
- 127
- Issue
- 2
- Pages
- 403-411
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- PMC
- PMC3355318
- OpenAlex
- W2166913840
- Cited by
- 188
- References
- 64
- Citations by year
- 2026: 10 · 2025: 3 · 2024: 10 · 2023: 17 · 2022: 20 · 2021: 17 · 2020: 19 · 2019: 9 · 2018: 16 · 2017: 12 · 2016: 16 · 2015: 11 · 2014: 13 · 2013: 12 · 2012: 3
- FWCI
- 14.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Toxicological Sciences (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, other-oa)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- drug toxicity, multicellular spheroids, HepG2 cells, LD50, LC50, in vitro-in vivo correlation, paracetamol, amiodarone, diclofenac, metformin, phenformin, valproic acid, 2D vs 3D culture comparison, hepatotoxicity
- MeSH terms
- Acetaminophen, Adenosine Triphosphate, Amiodarone, Diclofenac, Dose-Response Relationship, Drug, Humans, Lethal Dose 50, Metformin, Phenformin, Proteins, Valproic Acid, Reproducibility of Results, Risk Assessment, Toxicity Tests, Spheroids, Cellular, Bioreactors, Hepatocytes, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.